Zobrazeno 1 - 10
of 48
pro vyhledávání: '"George, Konstantonis"'
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objectives This study aimed to assess the performance of cardiovascular risk (CVR) prediction models reported by European Alliance of Associations for Rheumatology and European Society of Cardiology recommendations to identify high-atherosclerotic CV
Externí odkaz:
https://doaj.org/article/d8f22d225dff4062ba32c3136592246a
Publikováno v:
RMD Open, Vol 9, Iss 3 (2023)
Background To examine blood pressure (BP) and lipid treatment eligibility in antiphospholipid syndrome (APS) according to European Alliance of Associations for Rheumatology (EULAR) and European Society of Cardiology (ESC) recommendations.Methods Syst
Externí odkaz:
https://doaj.org/article/016f3013decb49f6a7efad41542eb867
Autor:
Maria G Tektonidou, Petros P Sfikakis, Stylianos Panopoulos, George Konstantonis, George C Drosos
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 1 (2023)
Objective Studies show that generic cardiovascular risk (CVR) prediction tools may underestimate CVR in SLE. We examined, for the first time to our knowledge, whether generic and disease-adapted CVR scores may predict subclinical atherosclerosis prog
Externí odkaz:
https://doaj.org/article/fe3345ac9d8a4e65961078f45dc5f454
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Background The European Alliance of Associations for Rheumatology recommended that lipid-lowering therapy (LLT) in systemic lupus erythematosus (SLE) should follow general population guidelines. We examined the eligibility for LLT in SLE according to
Externí odkaz:
https://doaj.org/article/9cdd18f8c78a4cea97ca94c431f6d81d
Autor:
Dimitrios Paraskevis, Konstantinos Mathioudakis, Anastasios Tsolakidis, Panagiota Mitrou, Georgia Vourli, George Konstantonis
Publikováno v:
RMD Open, Vol 7, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/0378b3d90e304369b1b8ce206807fa08
Autor:
George E. Fragoulis, Gerasimos Evangelatos, Nikolaos Tentolouris, Kalliopi Fragkiadaki, Stylianos Panopoulos, George Konstantonis, Alexios Iliopoulos, Katerina Chatzidionysiou, Petros P. Sfikakis, Maria G. Tektonidou
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Background: We explore the spectrum of comorbidities in psoriatic arthritis (PsA) patients in comparison with other high comorbidity-burden diseases like rheumatoid arthritis (RA) and diabetes mellitus (DM). Methods: Two hundred and fifteen PsA patie
Externí odkaz:
https://doaj.org/article/ca252c2fad1d4edbbc653e44decab720
Autor:
Nikolaos Papazoglou, Evrydiki Kravvariti, George Konstantonis, Petros P Sfikakis, Maria G Tektonidou
Publikováno v:
Rheumatology.
Objectives The 2022 EULAR recommendations for cardiovascular risk management in patients with rheumatic disorders, including SLE, call for rigorous management of cardiovascular risk factors (CVRF). The impact of CVRF target attainment on atherosclero
Autor:
George Konstantonis, Krishna V. Singh, Petros P. Sfikakis, Ankush D. Jamthikar, George D. Kitas, Suneet K. Gupta, Luca Saba, Kleio Verrou, Narendra N. Khanna, Zoltan Ruzsa, Aditya M. Sharma, John R. Laird, Amer M. Johri, Manudeep Kalra, Athanasios Protogerou, Jasjit S. Suri
Publikováno v:
Rheumatology International. 42:215-239
The study proposes a novel machine learning (ML) paradigm for cardiovascular disease (CVD) detection in individuals at medium to high cardiovascular risk using data from a Greek cohort of 542 individuals with rheumatoid arthritis, or diabetes mellitu
Autor:
Kyriaki Keramiotou, Christos Anagnostou, George Konstantonis, Kalliopi Fragiadaki, Evangelia Kataxaki, Petros P Sfikakis, Maria G Tektonidou
Publikováno v:
Rheumatology. 61:3808-3813
Objective The SLICC Frailty Index (SLICC-FI) was developed to assess health deficits including disease activity, organ damage, comorbidities and functional status. We examined any relationship between SLICC-FI and objective physical function measures
Autor:
Evrydiki Kravvariti, Gerasimos Evangelatos, George Konstantonis, Nikolaos Tentolouris, Maria G Tektonidou, Petros P. Sfikakis
Publikováno v:
Rheumatology. 61:3408-3413
Background Antiphospholipid syndrome (APS) is an autoimmune thrombophilia leading to life-threatening cardiovascular events. Cross-sectional data support that APS is associated with accelerated atherosclerosis, but this has not been confirmed in pros